ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 166 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $264,000 | +0.8% | 32,700 | -4.0% | 0.11% | -3.5% |
| Q1 2016 | $262,000 | -28.6% | 34,060 | 0.0% | 0.11% | -29.4% |
| Q4 2015 | $367,000 | +43.4% | 34,060 | -8.1% | 0.16% | +45.5% |
| Q3 2015 | $256,000 | -22.0% | 37,060 | 0.0% | 0.11% | -19.1% |
| Q2 2015 | $328,000 | -10.1% | 37,060 | 0.0% | 0.14% | -8.7% |
| Q1 2015 | $365,000 | -19.4% | 37,060 | +0.2% | 0.15% | -22.0% |
| Q4 2014 | $453,000 | +117.8% | 37,000 | +77.0% | 0.19% | +103.2% |
| Q3 2014 | $208,000 | – | 20,900 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |